E
Eva Harris
Researcher at University of California, Berkeley
Publications - 357
Citations - 26475
Eva Harris is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Dengue virus & Dengue fever. The author has an hindex of 84, co-authored 332 publications receiving 22718 citations.
Papers
More filters
Journal ArticleDOI
Dendritic Cells in Dengue Virus Infection: Targets of Virus Replication and Mediators of Immunity
TL;DR: It is suggested that DCs play a key role in priming DENV-specific neutralizing or potentially harmful memory B- and T-cell responses, and that future DC-directed therapies may help induce protective memory responses and reduce dengue pathogenesis.
Journal ArticleDOI
Homotypic Dengue Virus Reinfections in Nicaraguan Children
Jesse J. Waggoner,Angel Balmaseda,Lionel Gresh,Malaya K. Sahoo,Magelda Montoya,Chunling Wang,Janaki Abeynayake,Guillermina Kuan,Benjamin A. Pinsky,Eva Harris +9 more
TL;DR: The first set of virologically confirmed homotypic DENV reinfections are described, which challenge the current understanding of DENV immunity and have important implications for modeling DENV transmission.
Journal ArticleDOI
Rapid and specific detection of Asian- and African-lineage Zika viruses
Nunya Chotiwan,Connie D. Brewster,Tereza Magalhaes,Tereza Magalhaes,James Weger-Lucarelli,Nisha K. Duggal,Claudia Rückert,Chilinh Nguyen,Selene M. Garcia Luna,Joseph R. Fauver,Barb Andre,Meg Gray,William C. Black,Rebekah C. Kading,Gregory D. Ebel,Guillermina Kuan,Angel Balmaseda,Thomas Jaenisch,Ernesto T. A. Marques,Ernesto T. A. Marques,Aaron C. Brault,Eva Harris,Brian D. Foy,Sandra L. Quackenbush,Rushika Perera,Joel Rovnak +25 more
TL;DR: A rapid, specific, sensitive, and inexpensive method has been developed that detects RNA from a Zika virus strain associated with the current outbreak, and can also detect the African-lineage Zikairus strain using separate, specific primers.
Journal ArticleDOI
Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo.
TL;DR: It is demonstrated that EDIII-depleted human DENV-immune serum was protective against homologous DENV infection in vivo and could be replaced by neutralizing antibodies targeting other epitopes on the dengue virion.
Journal ArticleDOI
Genome-Wide Patterns of Intrahuman Dengue Virus Diversity Reveal Associations with Viral Phylogenetic Clade and Interhost Diversity
Poornima Parameswaran,Patrick Charlebois,Yolanda Tellez,Andrea Nuñez,Elizabeth M. Ryan,Christine M. Malboeuf,Joshua Z. Levin,Niall Lennon,Angel Balmaseda,Eva Harris,Matthew R. Henn +10 more
TL;DR: The abundance of viral variants within a host, as well as the impact of viral mutations on amino acid encoding and predicted protein function, determined whether intrahost variants were observed at the interhost level in circulating Nicaraguan DENV-2 populations, strongly suggestive of purifying selection across transmission events.